METHOD OF EXPRESS DIAGNOSTICS OF ONCOLOGICAL DISEASE Russian patent published in 2018 - IPC A61B5/05 

Abstract RU 2661098 C1

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to oncology, and can be used for express-determining the stages of development of the oncological process. Induction magnetoencephalogram is taken for 160 seconds, narrow-band spectral analysis of the obtained data and their transformation into the frequency matrix of the set of functional states and recognition of the disease. In each cell of the matrix, the amplitude of the spectral harmonic Ai and their dispersion Di are determined, calculate the value of each spectral cell as the reciprocal of their product and determine the decentralization index according to the expression Idc=∑1/(Ai×Di), where Idc – value of decentralization index in relative units; Ai – amplitude of the spectral harmonic; Di – its variance. Induction magnetoencephalogram is taken at least three times, with 30-second breaks. Each time the index of decentralization is determined. For recognition of the disease averaged calculated values of the decentralization index are used. After the first determination of the value of the decentralization index, a glucosopholia test is performed and repeated, no less than 40 and no more than 60 minutes after the test, re-determining the value of the decentralization index. Compare the primary and secondary indexes of decentralization. Depending on the results of the comparison, the patient is referred to one of the following stages of development of the oncological process: “no risk of cancer development”; “physiological precancer”, which is a condition characterized by the absence of clinical manifestations of cancer in the presence of risk factors for cancer; “morphological precancer”; “initial stage of cancer with weak activation of tumor growth”; “active stage of cancer with a significant progression of tumor growth”. “Absence of a risk of developing a cancer” is diagnosed if the primary and secondary decentralization indices are from 0 to 70 units, respectively and up to 170 units. “Physiological precancer” is diagnosed if the primary decentralization index is from 0 to 70 units, and the secondary index is from 170 units and higher. “Morphological precancer” is diagnosed if the primary decentralization index is more than 170 units, and the secondary one is lower by 0.2 or more from the primary value. “Initial stage of cancer with a weak activation of tumor growth” is diagnosed if the primary decentralization index is more than 170 units, and the secondary is equal to or no more than 0.2 above the primary value. “Active stage of cancer with a significant progression of tumor growth” is diagnosed if the primary decentralization index is more than 170 units, and the secondary one is more than 0.2 above the primary value.

EFFECT: method provides opportunity for objective diagnosis of the stages of development of the oncological process by comparing the indices of the decentralization index in dynamics.

4 cl, 1 dwg

Similar patents RU2661098C1

Title Year Author Number
METHOD FOR ASSESSMENT OF CONDITION OF HUMAN BODY 2021
  • Shabanov Gennadij Anatolevich
  • Rybchenko Aleksandr Alekseevich
  • Pegova Elena Valentinovna
  • Merkulova Galina Anatolevna
RU2781872C1
DIAGNOSTIC TECHNIQUE FOR RISK OF ANTITUMOR IMMUNE PROTECTION DEFICIENCY 2015
  • Dobrodeeva Lilija Konstantinovna
  • Patrakeeva Veronika Pavlovna
  • Stavinskaja Olga Aleksandrovna
RU2605310C1
METHOD FOR COMBINED ENDOSCOPIC DIAGNOSIS OF CHRONIC HYPERPLASTIC, PRECANCEROUS PROCESSES AND PRIMARY CANCERS OF LARYNX 2021
  • Cheremisina Olga Vladimirovna
  • Pankova Olga Vladimirovna
  • Taraskina Irina Olegovna
  • Mukhamedov Marat Rafkatovich
RU2752279C1
METHOD OF SELECTING PATIENTS IN THE LUNG CANCER RISK GROUP 2017
  • Lazarev Aleksandr Fedorovich
RU2644703C1
METHOD OF DETERMINING THE RISK OF MALIGNANT TRANSFORMATION OF EPITHELIAL CELLS OF THE LARYNX IN PATIENTS WITH PRECANCEROUS DISEASES OF THE LARYNX 2022
  • Sidenko Evgeniya Aleksandrovna
  • Kondakova Irina Viktorovna
  • Cheremisina Olga Vladimirovna
  • Sereda Elena Evgenevna
  • Kakurina Gelena Valerevna
RU2803858C1
METHOD OF DIAGNOSTICS OF UTERI CERVIX CANCER 2007
  • Bulgakov Aleksandr Aleksandrovich
  • Rodionova Ol'Ga Mikhajlovna
  • Apanasevich Vladimir Iosifovich
  • Petrova Irina Jur'Evna
  • Elisejkina Marina Gennad'Evna
RU2343485C1
METHOD FOR DETERMINING AUTOLOGOUS ANTICANCER ACTIVITY OF BLOOD NEUTROPHILS IN ONCOLOGICAL DISEASES 2020
  • Savchenko Andrej Anatolevich
  • Borisov Aleksandr Gennadevich
  • Modestov Andrej Arsenevich
  • Slepov Evgenij Vladimirovich
  • Gvozdev Ivan Igorevich
RU2737495C1
METHOD FOR DETERMINING THE BREAST CANCER RISK BY LAZAREV 2017
  • Lazarev Aleksandr Fedorovich
RU2651131C1
METHOD FOR PREDICTING RISK OF MALIGNANT NEW GROWTHS 2014
  • Ljutfalieva Gjul'Nara Tel'Manovna
RU2552305C1
METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF MECHANICAL JAUNDICE OF MALIGNANT GENESIS 2020
  • Smirnova Olga Valentinovna
  • Kasparov Eduard Vilyamovich
  • Gubanov Boris Gennadevich
RU2738310C1

RU 2 661 098 C1

Authors

Rybchenko Aleksandr Alekseevich

Shabanov Gennadij Anatolevich

Maksimov Arkadij Leonidovich

Ishchenko Vitalij Nikolaevich

Kryzhanovskij Sergej Petrovich

Dates

2018-07-11Published

2016-07-06Filed